tiprankstipranks
Voyager Therapeutics (VYGR)
NASDAQ:VYGR
US Market
VYGR
Voyager Therapeutics
RESEARCH TOOLSreports

Voyager Therapeutics (VYGR) Financial Statements

Compare
1,342 Followers

Voyager Therapeutics Financial Overview

Voyager Therapeutics's market cap is currently $246.15M. The company's EPS TTM is $-0.46; its P/E ratio is -1.93; Voyager Therapeutics is scheduled to report earnings on March 9, 2026, and the estimated EPS forecast is $-0.53. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 40.37M$ 80.00M$ 250.01M$ 40.91M$ 37.41M
Gross Profit$ 40.37M$ 80.00M$ 157.84M$ -14.86M$ -36.37M
Operating Income$ -131.84M$ -83.29M$ 122.01M$ -50.84M$ -73.62M
EBITDA$ -127.78M$ -78.56M$ 126.45M$ -39.65M$ -68.45M
Net Income$ -119.72M$ -65.00M$ 132.33M$ -46.41M$ -71.20M
Balance Sheet
Cash & Short-Term Investments$ 196.45M$ 266.68M$ 230.88M$ 118.85M$ 132.54M
Total Assets$ 252.28M$ 393.05M$ 351.28M$ 159.36M$ 193.85M
Total Debt$ 36.50M$ 43.73M$ 20.29M$ 23.13M$ 44.18M
Net Debt$ -28.80M$ -27.64M$ -48.51M$ -75.83M$ -73.25M
Total Liabilities$ 56.20M$ 93.29M$ 114.96M$ 100.34M$ 98.80M
Stockholders' Equity$ 196.08M$ 299.76M$ 236.32M$ 59.02M$ 95.06M
Cash Flow
Free Cash Flow$ -135.06M$ -18.83M$ 74.66M$ -15.00M$ -55.13M
Operating Cash Flow$ -132.47M$ -15.31M$ 77.92M$ -12.51M$ -53.52M
Investing Cash Flow$ 125.45M$ -94.86M$ -141.64M$ -7.34M$ 65.91M
Financing Cash Flow$ 816.00K$ 114.02M$ 33.65M$ 1.11M$ 612.00K
Currency in USD

Voyager Therapeutics Earnings and Revenue History

Income Statement >

Voyager Therapeutics Debt to Assets

Balance Sheet >

Voyager Therapeutics Cash Flow

Cash Flow >

Voyager Therapeutics Forecast EPS vs Actual EPS

Earnings >